Additional file 1: Table S1. Information of patients and samples. Table S2. The differentially expressed analysis of PCa. Table S3. The proteomic pathway-based classification for PCa
Abstract Tumor metabolism patterns have been reported to be associated with the prognosis of many ca...
Additional file 8: Table S2. Free prostate specific antigen (fPSA), total PSA (tPSA), free to total...
Sample purity. Figure S2. Sample dissimilarity. Figure S3. Unsupervised clustering and heatmaps. Fig...
Table S7. Metabolic and EMT subtypes of CTCs in non-metastatic and metastatic PCa patients (Cohort 2...
The clinical parameters of the tumors used in the 2D-DIGE analysis are given in this table: Sex, tum...
Prostate cancer (PCa) is a heterogeneous group of tumors with variable clinical courses. In order to...
Additional file 1. Table with PC-3 ChEMBL assays used to retrieve compounds activitie
Additional file 1: Table S1. Metabolites identified by 1H HR MAS NMR in prostate tissue samples
Additional file 1. Supplementary files. Supplementary table 1. Distribution of pT and miT. Supplemen...
Objective Prostate cancer (PCa) is a malignant neoplasm of the urinary system. This study aimed to u...
Additional file 3: Table S3. Compared with CC groups, the 22 upregulated and 66 downregulated DEPs i...
Containing detailed description of materials and methods, modeling, supplementary tables and supplem...
Table S1. Correlations. Spearman’s rank correlations for the PMR values of each biomarker, ProCUrE, ...
Table S5. Weighted scores of the metabolic gene candidates calculated by the AHP-based model. (DOCX ...
Patients with metastatic prostate cancer (PCa) have a poorer prognosis than patients with organ-conf...
Abstract Tumor metabolism patterns have been reported to be associated with the prognosis of many ca...
Additional file 8: Table S2. Free prostate specific antigen (fPSA), total PSA (tPSA), free to total...
Sample purity. Figure S2. Sample dissimilarity. Figure S3. Unsupervised clustering and heatmaps. Fig...
Table S7. Metabolic and EMT subtypes of CTCs in non-metastatic and metastatic PCa patients (Cohort 2...
The clinical parameters of the tumors used in the 2D-DIGE analysis are given in this table: Sex, tum...
Prostate cancer (PCa) is a heterogeneous group of tumors with variable clinical courses. In order to...
Additional file 1. Table with PC-3 ChEMBL assays used to retrieve compounds activitie
Additional file 1: Table S1. Metabolites identified by 1H HR MAS NMR in prostate tissue samples
Additional file 1. Supplementary files. Supplementary table 1. Distribution of pT and miT. Supplemen...
Objective Prostate cancer (PCa) is a malignant neoplasm of the urinary system. This study aimed to u...
Additional file 3: Table S3. Compared with CC groups, the 22 upregulated and 66 downregulated DEPs i...
Containing detailed description of materials and methods, modeling, supplementary tables and supplem...
Table S1. Correlations. Spearman’s rank correlations for the PMR values of each biomarker, ProCUrE, ...
Table S5. Weighted scores of the metabolic gene candidates calculated by the AHP-based model. (DOCX ...
Patients with metastatic prostate cancer (PCa) have a poorer prognosis than patients with organ-conf...
Abstract Tumor metabolism patterns have been reported to be associated with the prognosis of many ca...
Additional file 8: Table S2. Free prostate specific antigen (fPSA), total PSA (tPSA), free to total...
Sample purity. Figure S2. Sample dissimilarity. Figure S3. Unsupervised clustering and heatmaps. Fig...
DOI
Add to ORKG